PTPN1; | |
PTGES; ALOX12; HSD11B1; | |
MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | PTGES | Prostaglandin E synthase | O14684 | CHEMBL5658 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 7.172E-07 | 5.205E-03 | ALOX12, CYP2C9, PTGES |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 6.752E-07 | 5.205E-03 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.687E-06 | 9.186E-03 | CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 7.417E-06 | 1.615E-02 | CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 7.417E-06 | 1.615E-02 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.905E-05 | 3.191E-02 | ALOX12, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008610; lipid biosynthetic process | 2.172E-05 | 3.378E-02 | ALOX12, CYP3A4, HSD11B1, PTGES |
MF | GO:0005488; binding | GO:0051721; protein phosphatase 2A binding | 4.236E-05 | 5.765E-02 | MAPT, PTPN1 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 6.281E-05 | 7.408E-02 | CYP2C9, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.106E-04 | 1.095E-01 | CYP2C9, CYP3A4 |
CC | GO:0044464; cell part | GO:0097443; sorting endosome | 2.173E-03 | 4.593E-01 | PTPN1 |
CC | GO:0044464; cell part | GO:0005641; nuclear envelope lumen | 2.896E-03 | 5.390E-01 | PTGES |
CC | GO:0044464; cell part | GO:0030673; axolemma | 5.785E-03 | 7.728E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.842E-07 | 1.302E-05 | CYP2C9, ALOX12, PTGES |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.616E-06 | 1.302E-05 | HSD11B1, CYP2C9, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.711E-05 | 7.273E-05 | HSD11B1, CYP2C9, ALOX12, CYP3A4, PTGES |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.298E-06 | 1.302E-05 | HSD11B1, CYP2C9, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 4.244E-05 | 1.443E-04 | CYP2C9, CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 2.161E-04 | 5.177E-04 | CYP2C9, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.720E-04 | 4.872E-04 | HSD11B1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.436E-04 | 5.177E-04 | CYP2C9, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 6.408E-04 | 1.210E-03 | CYP2C9, ALOX12 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.599E-02 | 2.719E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Lipid metabolism disorder | E75-E78 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | HSD11B1; |
I00-I99: Diseases of the circulatory system | Atherosclerosis | I70 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic syndrome x | E88.81 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Hypercholesterolemia | E78 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | HSD11B1; |
J00-J99: Diseases of the respiratory system | Influenza virus | J11.1 | HSD11B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | HSD11B1; |